lucifer yellow

Subscribe to Selected New Research on lucifer yellow

119 relevant articles (0 outcomes, 8 trials/studies) found for this Bio-Agent

Description: RN given refers to di-Li salt

Also Known As:

dilithium 6-amino-2-((hydrazinocarbonyl)amino)-2, 3-dihydro-1,3-dioxo-1H-benz(de)isoquinoline-5,8- disulfonate; lucifer yellow CH; 1H-Benz(de)isoquinoline-2(3H)-carboxylic acid, 6-amino-1,3-dioxo-5,8-disulfo-, 2-hydrazide, dilithium salt

Bio-Agent Context: Research Results

Heterocyclic Compounds: 23

2-Ring Heterocyclic Compounds

Isoquinolines: 17

lucifer yellow: 119

Experts

1.	Naito, Jumpei: 1 article (02/2004)
2.	Chen, Yaoxing: 1 article (02/2004)

Related Diseases

1.	Ganglion Cysts (Ganglion) 03/08/1988 - "Since the stratification patterns of the displaced and nondisplaced type 1 neurones were indistinguishable, it is reasonable to assume that the Lucifer Yellow-filled cells in the present study represent the displaced counterpart of regular type 1 ganglion cells.(ABSTRACT TRUNCATED AT 250 WORDS)" 10/01/2007 - "Subsequently, quantified values of dendritic thickness, number of branching points and level of stratification of 73 Lucifer yellow-filled ganglion cells were analyzed by statistical methods, resulting in a classification into 9 groups" 07/01/2006 - "Immunostaining of Lucifer yellow-labeled neurons revealed that CPT interneurons projected an axonal process to the contralateral pedal ganglion" 01/01/2005 - "We used immunocytochemistry, backfilling ganglion cells with fluorescent dextranes and microinjection of Lucifer Yellow, to visualize the micromorphology of the various cell types in a confocal microscope" 02/09/2004 - "Morphologic analysis and classification of ganglion cells of the chick retina by intracellular injection of Lucifer Yellow and retrograde labeling with DiI." Get all the results and reference details, order at left...
2.	Neoplasms (Cancer) 09/01/1992 - "In cell-cell communication studies, the normal cells transferred Lucifer yellow, while tumor cells failed to show dye transfer" 10/01/2000 - "Using the scrape-loading assay dye-transfer technique to introduce 0.05% Lucifer yellow into cells, we measured the ability of the tumor cells to transfer dye to adjacent cells" 01/01/1996 - "1. We have used multiple, simultaneous intra- and extracellular recordings as well as Lucifer yellow dye-fills to identify modulatory commissural neuron 5 (MCN5) and characterize its effects in the stomatogastric nervous system (STNS) of the crab, Cancer borealis" 04/01/1994 - "Treatment of BWEM cells with the tumor promoting agent 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibited intercellular passage of microinjected Lucifer yellow" 01/01/1991 - "The cells were then recultured, and we measured their JC in vitro by the dye transfer method with the fluorescent dye Lucifer yellow CH, and found that the homologous (tumor cell-tumor cell) JC of highly metastatic clones were less in recultured tumor cells from primary tumors than that of weakly metastatic clones" Get all the results and reference details, order at left...
3.	Experimental Liver Neoplasms 01/01/1987 - "In the present study, junctional permeance (PA, i.e., the product of the junctional permeability coefficient, P, times the junctional area, A) to Lucifer Yellow CH (LY) has been obtained for pairs of Novikoff hepatoma cells" 01/01/1995 - "Lucifer Yellow was microinjected into Novikoff hepatoma cells and leakage was investigated under treatment with ATP (5 mM) and EGTA (5 mM) in the culture medium" Get all the results and reference details, order at left...
4.	Psoriasis (Pustulosis Palmaris et Plantaris) 01/01/2006 - "In order to further characterize the role of dendritic cells in psoriasis, this study was designed to assess the differentiation of dendritic cells from monocytes (MoDC), the expression of phagocytosis related receptors by MoDC, their endocytic activity for fluorescent beads and lucifer yellow as well as their superoxide generation in patients with psoriasis" Get all the results and reference details, order at left...
5.	Anoxia (Hypoxia) 07/12/2005 - "In addition, studies with rat primary-cultured cardiomyocytes demonstrated that acetylcholine effectively prevented the hypoxia-induced loss of phosphorylated Cx43 and ameliorated the loss of cell-to-cell communication as determined by Lucifer Yellow dye transfer assay, which supports the in vivo results" Get all the results and reference details, order at left...
35 Diseases and 119 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Dextrans (Dextran)
2.	Connexin 43 (Connexin43)
3.	Connexins
4.	Superoxides (Superoxide)
5.	Acetylcholine (Acetylcholine Chloride)
6.	Horseradish Peroxidase
7.	neurobiotin
8.	Rhodamines
9.	Retinaldehyde (Retinal)
10.	Fluorescein (Funduscein)
71 Drugs and Important Bio-Agents and 58 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Microelectrodes
2.	Lasers (Laser)
3.	Microspheres (Microsphere)
4.	Electrodes (Electrode)
4 Therapies and Procedures and 6 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>